Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).

Zhang R, Kim YM, Wang X, Li Y, Lu X, Sternenberger AR, Li S, Lee JY.

Int J Med Sci. 2015 Sep 1;12(9):719-26. doi: 10.7150/ijms.12612. eCollection 2015.

2.

Microarray-based genomic profiling and in situ hybridization on fibrotic bone marrow biopsies for the identification of numerical chromosomal abnormalities in myelodysplastic syndrome.

Stevens-Kroef MJ, Hebeda KM, Verwiel ET, Kamping EJ, van Cleef PH, Kuiper RP, Groenen PJ.

Mol Cytogenet. 2015 May 28;8:33. doi: 10.1186/s13039-015-0136-5. eCollection 2015.

3.

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL.

Blood. 2015 Jul 2;126(1):9-16. doi: 10.1182/blood-2015-03-631747. Epub 2015 Apr 30.

4.

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.

Gañán-Gómez I, Wei Y, Starczynowski DT, Colla S, Yang H, Cabrero-Calvo M, Bohannan ZS, Verma A, Steidl U, Garcia-Manero G.

Leukemia. 2015 Jul;29(7):1458-69. doi: 10.1038/leu.2015.69. Epub 2015 Mar 12. Review.

5.

MDS prognostic scoring systems – past, present, and future.

Jonas BA, Greenberg PL.

Best Pract Res Clin Haematol. 2015 Mar;28(1):3-13. doi: 10.1016/j.beha.2014.11.001. Epub 2014 Nov 11. Review.

6.

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.

Vercauteren SM, Starczynowski DT, Sung S, McNeil K, Salski C, Jensen CL, Bruyere H, Lam WL, Karsan A.

Br J Haematol. 2012 Feb;156(3):409-12. No abstract available.

7.

Molecular pathogenesis of myelodysplastic syndromes.

Visconte V, Selleri C, Maciejewski JP, Tiu RV.

Transl Med UniSa. 2014 Feb 4;8:19-30. eCollection 2014 Jan.

8.

Identification of novel genomic aberrations in AML-M5 in a level of array CGH.

Zhang R, Lee JY, Wang X, Xu W, Hu X, Lu X, Niu Y, Tang R, Li S, Li Y.

PLoS One. 2014 Apr 11;9(4):e87637. doi: 10.1371/journal.pone.0087637. eCollection 2014.

9.

Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?

Zeidan AM, Prebet T, Saad Aldin E, Gore SD.

Expert Rev Hematol. 2014 Apr;7(2):191-4. doi: 10.1586/17474086.2014.891437. Epub 2014 Feb 24.

10.

Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms.

Valli R, Pressato B, Marletta C, Mare L, Montalbano G, Curto FL, Pasquali F, Maserati E.

Mol Cytogenet. 2013 Dec 12;6(1):56. doi: 10.1186/1755-8166-6-56.

11.

Induction of myelodysplasia by myeloid-derived suppressor cells.

Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, Epling-Burnette P, Van Bijnen S, Dolstra H, Cannon J, Youn JI, Donatelli SS, Qin D, De Witte T, Tao J, Wang H, Cheng P, Gabrilovich DI, List A, Wei S.

J Clin Invest. 2013 Nov;123(11):4595-611.

12.

Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine.

Cluzeau T, Moreilhon C, Mounier N, Karsenti JM, Gastaud L, Garnier G, Re D, Montagne N, Gutnecht J, Auberger P, Fuzibet JG, Cassuto JP, Raynaud S.

Blood Cancer J. 2013 Nov 1;3:e155. doi: 10.1038/bcj.2013.52.

13.

There's risk, and then there's risk: The latest clinical prognostic risk stratification models in myelodysplastic syndromes.

Zeidan AM, Komrokji RS.

Curr Hematol Malig Rep. 2013 Dec;8(4):351-60. doi: 10.1007/s11899-013-0172-3. Review.

14.

Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is regulated by protein palmitoylation.

Kong C, Lange JJ, Samovski D, Su X, Liu J, Sundaresan S, Stahl PD.

Biochem Biophys Res Commun. 2013 May 3;434(2):388-93. doi: 10.1016/j.bbrc.2013.04.001. Epub 2013 Apr 8.

15.

Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes.

Erdogan B, Bosompem A, Peng D, Han L, Smith E, Kennedy ME, Alford CE, Wu H, Zhao Z, Mosse CA, El-Rifai W, Kim AS.

Leuk Lymphoma. 2013 Dec;54(12):2720-7. doi: 10.3109/10428194.2013.790542. Epub 2013 May 15.

16.

The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

Otrock ZK, Tiu RV, Maciejewski JP, Sekeres MA.

Expert Rev Hematol. 2013 Feb;6(1):59-68. doi: 10.1586/ehm.12.67. Review.

17.

Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is mediated by CUL7 E3 ligase.

Kong C, Samovski D, Srikanth P, Wainszelbaum MJ, Charron AJ, Liu J, Lange JJ, Chen PI, Pan ZQ, Su X, Stahl PD.

PLoS One. 2012;7(9):e46485. doi: 10.1371/journal.pone.0046485. Epub 2012 Sep 27.

18.

Implication of microRNAs in the pathogenesis of MDS.

Fang J, Varney M, Starczynowski DT.

Curr Pharm Des. 2012;18(22):3170-9. Review.

19.

Not so benign haematology: anaemia of the elderly.

Merchant AA, Roy CN.

Br J Haematol. 2012 Jan;156(2):173-85. doi: 10.1111/j.1365-2141.2011.08920.x. Epub 2011 Nov 3. Review.

20.

A compressed sensing based approach for subtyping of leukemia from gene expression data.

Tang W, Cao H, Duan J, Wang YP.

J Bioinform Comput Biol. 2011 Oct;9(5):631-45.

Items per page

Supplemental Content

Write to the Help Desk